INTERFERON-?? IS NECESSARY FOR INITIATING THE ACUTE REJECTION OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II-DISPARATE SKIN ALLOGRAFTS1
- 1 May 1999
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 67 (10), 1362-1365
- https://doi.org/10.1097/00007890-199905270-00012
Abstract
Although interferon (IFN)gamma has immunostimulatory functions, it is not essential for the acute rejection of fully allogeneic grafts in mice. It is not known whether IFNgamma plays a critical role in the acute rejection of MHC class I- or MHC class II-disparate allografts. We studied the survival of skin allografts transplanted from fully allogeneic (BALB/c), MHC class I-disparate (bml), or MHC class II-disparate (bm12) donors to C57BL/6 wild-type (IFNgamma+/+) and IFNgamma gene-knockout (IFNgamma-/-) recipients. We also investigated the in vitro responses of IFNgamma+/+ and IFNgamma-/- T cells to MHC class II-disparate splenocytes. We found that IFNgamma-/- recipients reject BALB/c and bml skin grafts at the same rate as IFNgamma+/+ mice but are not capable of rejecting bm12 skin. Despite the inability of IFNgamma-/- mice to reject bm12 skin grafts, IFNgamma-/- T cells displayed vigorous proliferation and cytotoxic responses when stimulated with bm12 splenocytes in vitro. Furthermore, priming IFNgamma-/- recipients with bm12 splenocytes enabled these mice to reject bm12 skin grafts at a normal rate and to mount a cutaneous delayed-type hypersensitivity response to the bm12 antigen. The data demonstrate that IFNgamma is not necessary for generating effector mechanisms associated with acute transplant rejection but that it is required for initiating alloimmune responses to MHC class II-disparate skin grafts.Keywords
This publication has 13 references indexed in Scilit:
- INTERFERON-?? RECEPTOR SIGNALING IS NOT REQUIRED IN THE EFFECTOR PHASE OF THE ALLOIMMUNE RESPONSE1Transplantation, 1998
- ACUTE REJECTION OF VASCULARIZED HEART ALLOGRAFTS IN THE ABSENCE OF IFN??1,2Transplantation, 1996
- Interferon-γ: Biology and Role in PathogenesisAdvances in Immunology, 1996
- Interleukin 13 is a B cell stimulating factor.The Journal of Experimental Medicine, 1994
- Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ GenesScience, 1993
- Dissection of human Langerhans cells' allostimulatory function: The need for an activation step for full development of accessory functionEuropean Journal of Immunology, 1993
- Differential involvement of CD4+ cells in mediating skin graft rejection against different amounts of transgenic H-2K(b) antigen.The Journal of Experimental Medicine, 1991
- Migration and maturation of Langerhans cells in skin transplants and explants.The Journal of Experimental Medicine, 1990
- INDUCTION OF Ia ANTIGENS ON MURINE EPIDERMAL CELLS DURING THE REJECTION OF SKIN ALLOGRAFTSTransplantation, 1983
- The firstH- 2 mutant workshopImmunogenetics, 1978